The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

In zebrafish, ketamine causes changes a brain circuit involved in "giving up." That may help explain how the drug helps ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Patients who received the drug, called navacaprant, showed no more improvement in depressive symptoms than people who ...

Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Studies show that antidepressants don’t always work. One psychologist explains how to take control of negative thoughts ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

The study, first of the three late-stage trials, was testing the drug, navacaprant, in patients with major depressive ...

Ketamine’s promising potential to ease depression is one of the reasons why its use has recently skyrocketed in the US and ...

Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...